{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:30:04Z","timestamp":1765369804847,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009954","name":"Taiho Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018046","name":"Nippon Kayaku","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018046","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010793","name":"Pfizer Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12328-021-01407-5","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T15:02:35Z","timestamp":1621868555000},"page":"1014-1019","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Aggressive advanced gastric cancer in a patient with autosomal dominant polycystic kidney disease"],"prefix":"10.1007","volume":"14","author":[{"given":"Takeshi","family":"Yasuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5770-9710","authenticated-orcid":false,"given":"Takeshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Dohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohisa","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Kamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Inamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"key":"1407_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10157-012-0741-0","volume":"17","author":"T Mochizuki","year":"2013","unstructured":"Mochizuki T, Tsuchiya K, Nitta K. Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies. Clin Exp Nephrol. 2013;17:317\u201326.","journal-title":"Clin Exp Nephrol"},{"key":"1407_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","volume":"4","author":"C Bergmann","year":"2018","unstructured":"Bergmann C, Guay-Woodford LM, Harris PC, et al. Polycystic kidney disease. Nat Rev Dis Primers. 2018;4:50.","journal-title":"Nat Rev Dis Primers"},{"key":"1407_CR3","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","volume":"359","author":"JJ Grantham","year":"2008","unstructured":"Grantham JJ. Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med. 2008;359:1477\u201385.","journal-title":"N Engl J Med"},{"key":"1407_CR4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/0092-8674(94)90137-6","volume":"77","author":"The European Polycystic Kidney D","year":"1994","unstructured":"The European Polycystic Kidney D. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell. 1994;77:881\u201394.","journal-title":"Cell"},{"key":"1407_CR5","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1172\/JCI5111","volume":"104","author":"Y Huan","year":"1999","unstructured":"Huan Y, van Adelsberg J. Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. J Clin Invest. 1999;104:1459\u201368.","journal-title":"J Clin Invest"},{"key":"1407_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0002-9440(10)65575-7","volume":"153","author":"S Hirohashi","year":"1998","unstructured":"Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol. 1998;153:333\u20139.","journal-title":"Am J Pathol"},{"key":"1407_CR7","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S1097-2765(00)00123-4","volume":"6","author":"A Boletta","year":"2000","unstructured":"Boletta A, Qian F, Onuchic LF, et al. Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells. Mol Cell. 2000;6:1267\u201373.","journal-title":"Mol Cell"},{"key":"1407_CR8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/cbf.1417","volume":"25","author":"K Zhang","year":"2007","unstructured":"Zhang K, Ye C, Zhou Q, et al. PKD1 inhibits cancer cells migration and invasion via Wnt signaling pathway in vitro. Cell Biochem Funct. 2007;25:767\u201374.","journal-title":"Cell Biochem Funct"},{"key":"1407_CR9","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S1470-2045(16)30250-9","volume":"17","author":"T-M Yu","year":"2016","unstructured":"Yu T-M, Chuang Y-W, Yu M-C, et al. Risk of cancer in patients with polycystic kidney disease: a propensity-score matched analysis of a nationwide, population-based cohort study. Lancet Oncol. 2016;17:1419\u201325.","journal-title":"Lancet Oncol"},{"key":"1407_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11255-018-1951-5","volume":"51","author":"K Sun","year":"2019","unstructured":"Sun K, Xu D, Mei C. The association between autosomal dominant polycystic kidney disease and cancer. Int Urol Nephrol. 2019;51:93\u2013100.","journal-title":"Int Urol Nephrol"},{"key":"1407_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1056\/NEJMra022161","volume":"350","author":"PD Wilson","year":"2004","unstructured":"Wilson PD. Polycystic kidney disease. N Engl J Med. 2004;350:151\u201364.","journal-title":"N Engl J Med"},{"key":"1407_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ng0695-151","volume":"10","author":"J Hughes","year":"1995","unstructured":"Hughes J, Ward CJ, Peral B, et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet. 1995;10:151\u201360.","journal-title":"Nat Genet"},{"key":"1407_CR13","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1093\/hmg\/9.18.2743","volume":"9","author":"MS Scheffers","year":"2000","unstructured":"Scheffers MS, van der Bent P, Prins F, et al. Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells. Hum Mol Genet. 2000;9:2743\u201350.","journal-title":"Hum Mol Genet"},{"key":"1407_CR14","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.yexcr.2010.02.033","volume":"316","author":"N Basora","year":"2010","unstructured":"Basora N, Tetreault MP, Boucher MP, et al. Polycystin-1 is a microtubule-driven desmosome-associated component in polarized epithelial cells. Exp Cell Res. 2010;316:1454\u201364.","journal-title":"Exp Cell Res"},{"key":"1407_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000163955","volume":"63","author":"DN Wheatley","year":"1995","unstructured":"Wheatley DN. Primary cilia in normal and pathological tissues. Pathobiology. 1995;63:222\u201338.","journal-title":"Pathobiology"},{"key":"1407_CR16","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1681\/ASN.V124834","volume":"12","author":"PD Wilson","year":"2001","unstructured":"Wilson PD. Polycystin: new aspects of structure, function, and regulation. J Am Soc Nephrol. 2001;12:834\u201345.","journal-title":"J Am Soc Nephrol"},{"key":"1407_CR17","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1681\/ASN.2008060564","volume":"20","author":"MC Hogan","year":"2009","unstructured":"Hogan MC, Manganelli L, Woollard JR, et al. Characterization of PKD protein-positive exosome-like vesicles. J Am Soc Nephrol. 2009;20:278\u201388.","journal-title":"J Am Soc Nephrol"},{"key":"1407_CR18","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1038\/sj.bjc.6690308","volume":"79","author":"J Stone","year":"1999","unstructured":"Stone J, Bevan S, Cunningham D, et al. Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer. Br J Cancer. 1999;79:1935\u20137.","journal-title":"Br J Cancer"},{"key":"1407_CR19","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1038\/s41598-018-20856-6","volume":"8","author":"CC Lin","year":"2018","unstructured":"Lin CC, Kurashige M, Liu Y, et al. A cleavage product of Polycystin-1 is a mitochondrial matrix protein that affects mitochondria morphology and function when heterologously expressed. Sci Rep. 2018;8:2743.","journal-title":"Sci Rep"},{"key":"1407_CR20","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.ajpath.2017.05.002","volume":"187","author":"Y Kito","year":"2017","unstructured":"Kito Y, Saigo C, Takeuchi T. Novel transgenic mouse model of polycystic kidney disease. Am J Pathol. 2017;187:1916\u201322.","journal-title":"Am J Pathol"},{"key":"1407_CR21","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/carcin\/bgs001","volume":"33","author":"T Takeuchi","year":"2012","unstructured":"Takeuchi T, Adachi Y, Nagayama T. A WWOX-binding molecule, transmembrane protein 207, is related to the invasiveness of gastric signet-ring cell carcinoma. Carcinogenesis. 2012;33:548\u201354.","journal-title":"Carcinogenesis"},{"key":"1407_CR22","doi-asserted-by":"publisher","first-page":"109468","DOI":"10.1016\/j.cellsig.2019.109468","volume":"66","author":"JP Margaria","year":"2020","unstructured":"Margaria JP, Campa CC, De Santis MC, et al. The PI3K\/Akt\/mTOR pathway in polycystic kidney disease: a complex interaction with polycystins and primary cilium. Cell Signal. 2020;66:109468.","journal-title":"Cell Signal"},{"key":"1407_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1681\/ASN.2009040421","volume":"21","author":"JM Shillingford","year":"2010","unstructured":"Shillingford JM, Piontek KB, Germino GG, et al. Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1. J Am Soc Nephrol. 2010;21:489\u201397.","journal-title":"J Am Soc Nephrol"},{"key":"1407_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.semcancer.2019.07.003","volume":"59","author":"AK Murugan","year":"2019","unstructured":"Murugan AK. mTOR: role in cancer, metastasis and drug resistance. Semin Cancer Biol. 2019;59:92\u2013111.","journal-title":"Semin Cancer Biol"},{"key":"1407_CR25","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1158\/1078-0432.CCR-08-2138","volume":"15","author":"G Yu","year":"2009","unstructured":"Yu G, Wang J, Chen Y, et al. Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of Chinese patients with gastric cancer. Clin Cancer Res. 2009;15:1821\u20139.","journal-title":"Clin Cancer Res"},{"key":"1407_CR26","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000045070","volume":"79","author":"SA Aziz","year":"1998","unstructured":"Aziz SA, Ahmad M, Shah A. Carcinoma of the gastroesophageal junction associated with adult polycystic kidney disease. Nephron. 1998;79:362\u20133.","journal-title":"Nephron"},{"key":"1407_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3919\/jjsa.63.375","volume":"63","author":"S Tsukayama","year":"2002","unstructured":"Tsukayama S, Yamamura K. A case of gastric cancer with polycystic kidney. Nihon Rinsho Geka Gakkai Zasshi (J Jpn Surg Assoc). 2002;63:375\u20138.","journal-title":"Nihon Rinsho Geka Gakkai Zasshi (J Jpn Surg Assoc)"},{"key":"1407_CR28","doi-asserted-by":"publisher","first-page":"628","DOI":"10.5833\/jjgs.43.628","volume":"43","author":"H Yamanaka","year":"2010","unstructured":"Yamanaka H, Asamoto H, Ishizaka T, et al. A case of gastric cancer with autosomal dominant polycystic kidney disease. Jpn J Gastroenterol Surg. 2010;43:628\u201334.","journal-title":"Jpn J Gastroenterol Surg"},{"key":"1407_CR29","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1159\/000329179","volume":"5","author":"K Mimatsu","year":"2011","unstructured":"Mimatsu K, Oida T, Kawasaki A, et al. Multiple gastric carcinomas associated with potter type III cystic disease. Case Rep Gastroenterol. 2011;5:590\u20136.","journal-title":"Case Rep Gastroenterol"},{"key":"1407_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12253-015-9996-6","volume":"22","author":"YC Chen","year":"2016","unstructured":"Chen YC, Fang WL, Wang RF, et al. Clinicopathological variation of lauren classification in gastric cancer. Pathol Oncol Res. 2016;22:197\u2013202.","journal-title":"Pathol Oncol Res"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-021-01407-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-021-01407-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-021-01407-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T16:26:35Z","timestamp":1626971195000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-021-01407-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1407"],"URL":"https:\/\/doi.org\/10.1007\/s12328-021-01407-5","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2021,5,24]]},"assertion":[{"value":"18 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Takeshi Ishikawa received scholarship funds from Daiichi Sankyo Co. Ltd., Taiho Pharmaceutical Co. Ltd., and Nippon Kayaku Co. Ltd. Yoshito Itoh received scholarship funds from Daiichi Sankyo Co. Ltd. and Pfizer Japan Inc. Neither the funding agency nor any outside organization participated in the study design, and there are no competing interests. Drs. Takeshi Yasuda, Ryohei Hirose, Toshifumi Doi, Ken Inoue, Osamu Dohi, Naohisa Yoshida, Kazuhiro Kamada, Kazuhiko Uchiyama, Tomohisa Takagi, Hideyuki Konishi, Osamu Inamori, Yukiko Morinaga, Eiichi Konishi and Yuji Naito have no conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}